J P Diorio
Overview
Explore the profile of J P Diorio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosesson M, Cooley B, Hernandez I, Diorio J, Weiler H
J Thromb Haemost
. 2008 Nov;
7(1):102-10.
PMID: 18983496
Background And Objectives: Thrombin binding activity in murine fibrin (Antithrombin I) is restricted to its E domains inasmuch as murine gamma' chains (mu-gamma') do not bind thrombin. This feature prompted...
2.
Mosesson M, Diorio J, Hernandez I, Hainfeld J, Wall J, Grieninger G
Biophys Chem
. 2004 Dec;
112(2-3):209-14.
PMID: 15572250
Fibrinogen-420 is a minor subclass of human fibrinogen that is so named because of its higher molecular weight compared to fibrinogen-340, the predominant form of circulating fibrinogen. Each of the...
3.
Meh D, Mosesson M, Diorio J, Siebenlist K, Hernandez I, Amrani D, et al.
Blood Coagul Fibrinolysis
. 2001 Dec;
12(8):627-37.
PMID: 11734662
In this study, we investigated tissue-type plasminogen activator (tPA)-induced lysis of glutamic acid (glu)-plasminogen-containing or lysine (lys)-plasminogen-containing thrombin-induced fibrin clots. We measured clot development and plasmin-mediated clot disintegration by thromboelastography,...
4.
Amrani D, Diorio J, Delmotte Y
Ann N Y Acad Sci
. 2001 Jul;
936:566-79.
PMID: 11460516
This paper focuses on the use of commercial fibrin sealant (FS) in specific wound healing applications. This review is not intended to be all inclusive, but to examine in vitro...
5.
Meh D, Mosesson M, Siebenlist K, Simpson-Haidaris P, Brennan S, Diorio J, et al.
Thromb Res
. 2001 Jul;
103(1):63-73.
PMID: 11434947
Fibrinogen Naples I (Bbeta A68T) is characterized by defective thrombin binding and fibrinopeptide cleavage at the fibrinogen substrate site in the E domain. We evaluated the fibrinogen of three homozygotic...
6.
Siebenlist K, Mosesson M, Meh D, Diorio J, Albrecht R, Olson J
Blood Coagul Fibrinolysis
. 2000 Jun;
11(3):293-304.
PMID: 10870810
Fibrinogen Cedar Rapids is a heterozygous dysfibrinogenemia (gammaR275C) that was associated with thromboembolism during and following pregnancy in three second-generation family members who also were heterozygotic for factor V Leiden...
7.
Sugo T, Nakamikawa C, Takano H, Mimuro J, Yamaguchi S, Mosesson M, et al.
Blood
. 1999 Nov;
94(11):3806-13.
PMID: 10572095
A novel BbetaAsn-160 (TAA) to Ser (TGA) substitution has been identified in fibrinogen Niigata derived from a 64-year-old asymptomatic woman, who is heterozygotic for this abnormality. The mutation creates an...
8.
Mosesson M, Siebenlist K, Diorio J, Matsuda M, Hainfeld J, Wall J
J Clin Invest
. 1995 Aug;
96(2):1053-8.
PMID: 7635941
Intermolecular end-to-middle domain pairing between a thrombin-exposed 'A' polymerization site in the central 'E' domain of fibrin, and a constitutive complementary 'a' site in each outer 'D' domain ('D:E'), is...
9.
Mosesson M, Diorio J, Siebenlist K, Wall J, Hainfeld J
Blood
. 1993 Sep;
82(5):1517-21.
PMID: 8364202
Fibrin molecules polymerize to double-stranded fibrils by intermolecular end-to-middle domain pairing of complementary polymerization sites, accompanied by fibril branching to form a clot network. Mass/length measurements on scanning transmission electron...
10.
Koopman J, Haverkate F, Grimbergen J, Lord S, Mosesson M, Diorio J, et al.
J Clin Invest
. 1993 Apr;
91(4):1637-43.
PMID: 8473507
The molecular defect in the abnormal fibrinogen Dusart (Paris V) that is associated with thrombophilia was determined by sequence analysis of genomic DNA that had been amplified using the polymerase...